Kok Yoon Chee

601 total citations
28 papers, 280 citations indexed

About

Kok Yoon Chee is a scholar working on Psychiatry and Mental health, Clinical Psychology and Pharmacology. According to data from OpenAlex, Kok Yoon Chee has authored 28 papers receiving a total of 280 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Psychiatry and Mental health, 10 papers in Clinical Psychology and 8 papers in Pharmacology. Recurrent topics in Kok Yoon Chee's work include Schizophrenia research and treatment (12 papers), Treatment of Major Depression (7 papers) and Mental Health Treatment and Access (5 papers). Kok Yoon Chee is often cited by papers focused on Schizophrenia research and treatment (12 papers), Treatment of Major Depression (7 papers) and Mental Health Treatment and Access (5 papers). Kok Yoon Chee collaborates with scholars based in Malaysia, Singapore and Japan. Kok Yoon Chee's co-authors include Daniel Flanagan, Caitríona Cunningham, Naotaka Shinfuku, Norman Sartorius, Mian-Yoon Chong, Pichet Udomratn, Kang Sim, Shuyu Yang, Yu‐Tao Xiang and Shea Ping Yip and has published in prestigious journals such as International Journal of Environmental Research and Public Health, Journal of Psychiatric Research and Social Psychiatry and Psychiatric Epidemiology.

In The Last Decade

Kok Yoon Chee

25 papers receiving 271 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kok Yoon Chee Malaysia 11 145 69 60 47 41 28 280
Simona Tomassi Italy 11 126 0.9× 95 1.4× 48 0.8× 22 0.5× 12 0.3× 17 315
Mohammad Reza Fayyazı Bordbar Iran 11 100 0.7× 93 1.3× 28 0.5× 22 0.5× 39 1.0× 50 336
Jyoti Aggarwal United States 7 348 2.4× 120 1.7× 23 0.4× 98 2.1× 37 0.9× 17 572
Semra Ulusoy Kaymak Türkiye 9 127 0.9× 109 1.6× 16 0.3× 70 1.5× 75 1.8× 19 395
Sally Mustafa Canada 13 255 1.8× 126 1.8× 10 0.2× 73 1.6× 24 0.6× 29 408
Claire Dibben United Kingdom 9 234 1.6× 133 1.9× 36 0.6× 17 0.4× 78 1.9× 14 389
Anamaria Brăilean United Kingdom 11 139 1.0× 69 1.0× 10 0.2× 36 0.8× 68 1.7× 11 437
Elias Andreoulakis Greece 10 90 0.6× 76 1.1× 27 0.5× 23 0.5× 24 0.6× 17 297
Gabriela Peretti Wagner Brazil 8 148 1.0× 23 0.3× 17 0.3× 15 0.3× 44 1.1× 21 286
Johanna Klinger-König Germany 10 68 0.5× 104 1.5× 24 0.4× 45 1.0× 14 0.3× 34 274

Countries citing papers authored by Kok Yoon Chee

Since Specialization
Citations

This map shows the geographic impact of Kok Yoon Chee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kok Yoon Chee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kok Yoon Chee more than expected).

Fields of papers citing papers by Kok Yoon Chee

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kok Yoon Chee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kok Yoon Chee. The network helps show where Kok Yoon Chee may publish in the future.

Co-authorship network of co-authors of Kok Yoon Chee

This figure shows the co-authorship network connecting the top 25 collaborators of Kok Yoon Chee. A scholar is included among the top collaborators of Kok Yoon Chee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kok Yoon Chee. Kok Yoon Chee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chee, Kok Yoon, et al.. (2024). Impact of body mass index elevation, Vitamin D receptor polymorphisms and antipsychotics on the risk of Vitamin D deficiency in schizophrenia patients. Journal of Psychiatric Research. 175. 350–358. 4 indexed citations
2.
Chee, Kok Yoon, et al.. (2023). Ictal Electroencephalogram Visual Pattern Recognition of Seizure Adequacy During Electroconvulsive Therapy Treatment: A Step-by-Step Approach. Malaysian Journal of Medical Sciences. 30(2). 83–89. 1 indexed citations
3.
Chee, Kok Yoon, Nurmiati Amir, Lai Fong Chan, et al.. (2022). A Southeast Asian expert consensus on the management of major depressive disorder with suicidal behavior in adults under 65 years of age. BMC Psychiatry. 22(1). 489–489. 4 indexed citations
4.
Amir, Nurmiati, Johnson Fam, Roger Ho, et al.. (2022). A Southeast Asia Consensus on the Definition and Management of Treatment-Resistant Depression. Neuropsychiatric Disease and Treatment. Volume 18. 2747–2757. 7 indexed citations
5.
Gaillard, Frank, et al.. (2020). Depression preceding Marchiafava–Bignami disease. Australian & New Zealand Journal of Psychiatry. 55(2). 224–225.
6.
Sulaiman, Ahmad Hatim, Kok Yoon Chee, Ong Hui Koh, et al.. (2020). Elucidating Mental Health Disorders among Rohingya Refugees: A Malaysian Perspective. International Journal of Environmental Research and Public Health. 17(18). 6730–6730. 18 indexed citations
7.
Park, Seon‐Cheol, Adarsh Tripathi, Ajit Avasthi, et al.. (2020). RELATIONSHIP BETWEEN BODY MASS INDEX AND EXTRAPYRAMIDAL SYMPTOMS IN ASIAN PATIENTS WITH SCHIZOPHRENIA: THE RESEARCH ON ASIAN PSYCHOTROPIC PRESCRIPTION PATTERNS FOR ANTIPSYCHOTICS (REAP-AP). Psychiatria Danubina. 32(2). 176–186. 5 indexed citations
8.
9.
Park, Seon‐Cheol, Adarsh Tripathi, Roy Abraham Kallivayalil, et al.. (2019). Cannabis use correlates with aggressive behavior and long-acting injectable antipsychotic treatment in Asian patients with schizophrenia. Nordic Journal of Psychiatry. 73(6). 323–330. 11 indexed citations
10.
Park, Yong Chon, Shigenobu Kanba, Mian‐Yoon Chong, et al.. (2017). To use the brief psychiatric rating scale to detect disorganized speech in schizophrenia: Findings from the REAP‐AP study. The Kaohsiung Journal of Medical Sciences. 34(2). 113–119. 6 indexed citations
11.
Park, Seon‐Cheol, Min-Soo Lee, Sang‐Woo Hahn, et al.. (2016). Suicidal thoughts/acts and clinical correlates in patients with depressive disorders in Asians: results from the REAP-AD study. Acta Neuropsychiatrica. 28(6). 337–345. 17 indexed citations
12.
13.
Chee, Kok Yoon, et al.. (2014). A review of schizophrenia research in malaysia.. PubMed. 69 Suppl A. 46–54. 7 indexed citations
14.
Xiang, Yu‐Tao, Chuanyue Wang, Tianmei Si, et al.. (2011). Tardive dyskinesia in the treatment of schizophrenia: the findings of the Research on Asian Psychotropic Prescription Pattern (REAP) survey (2001 – 2009). International Journal of Clinical Pharmacology and Therapeutics. 49(6). 382–387. 10 indexed citations
15.
Xiang, Yu‐Tao, Chuanyue Wang, Tianmei Si, et al.. (2011). Use of Anticholinergic Drugs in Patients with Schizophrenia in Asia from 2001 to 2009. Pharmacopsychiatry. 44(3). 114–118. 13 indexed citations
16.
Chee, Kok Yoon. (2010). Determinants of subjective quality of life in first‐episode schizophrenia: perspective from Malaysia. Early Intervention in Psychiatry. 4(2). 111–118. 12 indexed citations
17.
18.
Chee, Kok Yoon. (2008). Outcome study of first-episode schizophrenia in a developing country: quality of life and antipsychotics. Social Psychiatry and Psychiatric Epidemiology. 44(2). 143–150. 13 indexed citations
19.
Kapur, Navneet, et al.. (2003). Deliberate Self-Harm at Sarawak General Hospital. Research Explorer (The University of Manchester). 10(4). 277–282. 3 indexed citations
20.
Yip, Shea Ping, et al.. (2002). Molecular genetic analysis of para‐Bombay phenotypes in Chinese: a novel non‐functional FUT1 allele is identified. Vox Sanguinis. 83(3). 258–262. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Simona Tomassi Breakdown of academic impact, for papers by Mohammad Reza Fayyazı Bordbar Breakdown of academic impact, for papers by Jyoti Aggarwal Breakdown of academic impact, for papers by Semra Ulusoy Kaymak Breakdown of academic impact, for papers by Sally Mustafa Breakdown of academic impact, for papers by Claire Dibben Breakdown of academic impact, for papers by Anamaria Brăilean Breakdown of academic impact, for papers by Elias Andreoulakis Breakdown of academic impact, for papers by Gabriela Peretti Wagner Breakdown of academic impact, for papers by Johanna Klinger-König
Rankless by CCL
2026